Apollomics (APLM) Accounts Payables (2023)

Apollomics (APLM) posted quarterly Accounts Payables of $947000.0 for Q2 2023.

Apollomics (APLM) Accounts Payables (2023) Analysis & Trends

Apollomics (APLM) has reported Accounts Payables for 1 consecutive years, with $947000.0 the latest figure, recorded in Q2 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Accounts Payables (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	429.50 Mn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	1.16 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	1.52 Bn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	167.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	470.30 Mn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	108.02 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	622.65 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	428.93 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	35.57 Mn
10	Apollomics	35.18 Mn	31.90 Mn	-	-

Download Data

Date	Value
Jun 30, 2023	947,000.00